Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Asset disposition
Inv. presentation
Quarterly results

Strongbridge Biopharma plc (SBBP) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/11/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/05/2022 SC 13D/A CAXTON CORP reports a 0% stake in Strongbridge Biopharma plc
01/05/2022 4 CDK ASSOCIATES, L.L.C. (10% Owner) has filed a Form 4 on Strongbridge Biopharma plc
Txns: Disposed of 8,060,682 shares @ $0
Disposed of 2,220,000 options to buy @ $2.5, valued at $5.6M
10/25/2021 SC 13D/A Growth Equity Opportunities Fund III, LLC has filed a Schedule 13D for Strongbridge Biopharma plc
10/15/2021 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
10/07/2021 EFFECT Form EFFECT - Notice of Effectiveness:
10/07/2021 EFFECT Form EFFECT - Notice of Effectiveness:
10/07/2021 EFFECT Form EFFECT - Notice of Effectiveness:
10/06/2021 4 Wilhoit Scott L. (Chief Commercial Officer) has filed a Form 4 on Strongbridge Biopharma plc
Txns: Disposed/sold 109,510 shares @ $0
Disposed/sold 649,000 options to buy @ $0
10/06/2021 4 Kollender Richard S (President and CFO) has filed a Form 4 on Strongbridge Biopharma plc
Txns: Disposed/sold 234,229 shares @ $0
Disposed/sold 544,918 options to buy @ $0
10/06/2021 4 Cohen Fredric J. (Chief Medical Officer) has filed a Form 4 on Strongbridge Biopharma plc
Txns: Disposed/sold 160,408 shares @ $0
Disposed/sold 868,818 options to buy @ $0
10/06/2021 4 JOHNSON JOHN (CEO) has filed a Form 4 on Strongbridge Biopharma plc
Txns: Disposed/sold 610,092 shares @ $0
Disposed/sold 495,724 options to buy @ $0
10/06/2021 4 Steineger Hilde H (Director) has filed a Form 4 on Strongbridge Biopharma plc
Txns: Disposed/sold 64,258 shares @ $0
Disposed/sold 154,918 options to buy @ $0
10/06/2021 4 Steen Marten (Director) has filed a Form 4 on Strongbridge Biopharma plc
Txns: Disposed/sold 64,151 shares @ $0
Disposed/sold 154,918 options to buy @ $0
10/06/2021 4 SHERMAN JEFFREY W (Director) has filed a Form 4 on Strongbridge Biopharma plc
Txns: Disposed/sold 64,258 shares @ $0
Disposed/sold 140,000 options to buy @ $0
10/06/2021 4 Kong Garheng (Director) has filed a Form 4 on Strongbridge Biopharma plc
Txns: Disposed/sold 63,993 shares @ $0
Disposed/sold 154,385 options to buy @ $0
10/06/2021 4 GILL DAVID N (Director) has filed a Form 4 on Strongbridge Biopharma plc
Txns: Disposed/sold 78,058 shares @ $0
10/06/2021 4 LONG STEPHEN J (Chief Legal Officer) has filed a Form 4 on Strongbridge Biopharma plc
Txns: Disposed/sold 117,793 shares @ $0
Disposed/sold 714,045 options to buy @ $0
10/05/2021 4 Wilhoit Scott L. (Chief Commercial Officer) has filed a Form 4 on Strongbridge Biopharma plc
Txns: Paid exercise price by delivering 27,515 shares @ $2.06, valued at $56.7k
10/05/2021 4 LONG STEPHEN J (Chief Legal Officer) has filed a Form 4 on Strongbridge Biopharma plc
Txns: Paid exercise price by delivering 49,307 shares @ $2.06, valued at $101.6k
10/05/2021 4 Kollender Richard S (President and CFO) has filed a Form 4 on Strongbridge Biopharma plc
Txns: Paid exercise price by delivering 64,791 shares @ $2.06, valued at $133.5k
10/05/2021 4 Cohen Fredric J. (Chief Medical Officer) has filed a Form 4 on Strongbridge Biopharma plc
Txns: Paid exercise price by delivering 51,548 shares @ $2.06, valued at $106.2k
10/05/2021 4 Steen Marten (Director) has filed a Form 4 on Strongbridge Biopharma plc
Txns: Paid exercise price by delivering 17,763 shares @ $2.06, valued at $36.6k
10/05/2021 4 JOHNSON JOHN (CEO) has filed a Form 4 on Strongbridge Biopharma plc
Txns: Paid exercise price by delivering 334,868 shares @ $2.06, valued at $689.8k
10/05/2021 4 Steineger Hilde H (Director) has filed a Form 4 on Strongbridge Biopharma plc
Txns: Paid exercise price by delivering 17,763 shares @ $2.06, valued at $36.6k
10/05/2021 4 SHERMAN JEFFREY W (Director) has filed a Form 4 on Strongbridge Biopharma plc
Txns: Paid exercise price by delivering 17,763 shares @ $2.06, valued at $36.6k
10/05/2021 4 Kong Garheng (Director) has filed a Form 4 on Strongbridge Biopharma plc
Txns: Paid exercise price by delivering 17,763 shares @ $2.06, valued at $36.6k
10/05/2021 4 GILL DAVID N (Director) has filed a Form 4 on Strongbridge Biopharma plc
Txns: Paid exercise price by delivering 17,763 shares @ $2.06, valued at $36.6k
10/05/2021 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
10/05/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/05/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/05/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/05/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/05/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy